RESULTS	Treatment with omalizumab significantly decreased WA/BSA ( p < 0.01 ) , WA % ( p < 0.01 ) , and T/BSA ( p < 0.01 ) , and increased Ai/BSA ( p < 0.05 ) , whereas conventional therapy resulted in no change .\